Stocks and Investing
Stocks and Investing
Fri, May 26, 2023
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
Matthew Biegler Reiterated (ZNTL) at Buy and Held Target at $50 on, May 26th, 2023
Matthew Biegler of Oppenheimer, Reiterated "Zentalis Pharmaceuticals, Inc." (ZNTL) at Buy and Held Target at $50 on, May 26th, 2023.
Matthew has made no other calls on ZNTL in the last 4 months.
There are 2 other peers that have a rating on ZNTL. Out of the 2 peers that are also analyzing ZNTL, 0 agree with Matthew's Rating of Hold.
These are the ratings of the 2 analyists that currently disagree with Matthew
- Bradley Canino of "Stifel" Maintained at Strong Buy and Held Target at $45 on, Tuesday, May 23rd, 2023
- Biren Amin of "Jefferies" Maintained at Strong Buy with Decreased Target to $70 on, Friday, May 19th, 2023
Contributing Sources